Results 101 to 110 of about 30,843 (290)

Supplemental peri-operative intravenous crystalloids for postoperative nausea and vomiting: an abridged Cochrane systematic review. [PDF]

open access: yes, 2020
We conducted a Cochrane systematic review on the effectiveness of supplemental intravenous crystalloid administration in preventing postoperative nausea and vomiting.
Bird, SJ   +5 more
core  

Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study [PDF]

open access: yes, 2011
Background Chemotherapy-induced nausea and vomiting (CINV) are major adverse effects of cancer chemotherapy. This study investigated: (1) the impact of CINV on patients' health-related quality of life (HRQL) in daily clinical practice; (2) the ...
A Molassiotis   +26 more
core   +3 more sources

ANTIEMETIC ACTIVITIES OF INDONESIAN STINGLESS BEE PROPOLIS ON EMETIC INDUCED BY ANTI-TUBERCULOSIS DRUGS [PDF]

open access: yes, 2021
Objective: This study aims to determine the antiemetic potential of stingless bee propolis in reducing the prevalence of nausea due to consumption of Anti-Tuberculosis Drugs (ATD) in Tuberculosis patients and to identify phytochemical compounds that act ...
FATURACHMAN, FIRMANSYAH   +8 more
core   +1 more source

Opportunities and Challenges of Population Pharmacogenomics

open access: yesAnnals of Human Genetics, EarlyView.
ABSTRACT Pharmacological responses can vary significantly among patients from different ethnogeographic backgrounds. This variability can, at least in part, be attributed to population‐specific genetic patterns in genes involved in drug absorption, distribution, metabolism, and excretion, as well as in genes associated with drug‐induced toxicity ...
Yitian Zhou   +3 more
wiley   +1 more source

Nausea, Vomiting and Retching of Patients with Cervical Cancer Undergoing Chemotherapy in Bali, Indonesia [PDF]

open access: yes, 2012
Background: Nausea, vomiting and retching (NVR) was the frequently reported and troublesome adverse effect for patients receiving chemotherapy. Purpose: This study is a part of a larger study which aims to describe the NVR symptom experience in cervical ...
Chongchareon, W. (Wimonrat)   +2 more
core   +1 more source

Systematic review on the recurrence of postoperative nausea and vomiting after a first episode in the recovery room – implications for the treatment of PONV and related clinical trials [PDF]

open access: yes, 2006
BACKGROUND: Despite the presence of a plethora of publications on the prevention of postoperative nausea and vomiting (PONV) only little is known how to treat established symptoms.
A Boghaert   +60 more
core   +2 more sources

Approach to the Management of Gastrointestinal Manifestations in Patients With Phaeochromocytoma and Paraganglioma

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective Managing gastrointestinal symptoms in patients with phaeochromocytoma and paraganglioma (PPGL) is challenging due to the risk of catecholaminergic crisis with many commonly prescribed medications, especially in functional tumours.
Monica Majumder   +5 more
wiley   +1 more source

How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literature

open access: yesClinical Parkinsonism & Related Disorders, 2023
Introduction: Pretreatment with the antiemetic trimethobenzamide has been recommended practice in the United States (US) to address the risk of nausea and vomiting during initiation of apomorphine treatment.
Stuart H. Isaacson   +3 more
doaj  

Practice of use of antiemetic in patients for laparoscopic gynaecological surgery and its impact on the early (1st two hrs) postoperative period [PDF]

open access: yes, 2008
There is no agreed technique for minimizing PONV (Postoperative Nausea and Vomiting) although some techniques are associated with low rate. Best practice involves identifying high risk patients and surgeries and use of prophylactic antiemetic where ...
Ismail, Samina
core   +1 more source

Adverse events and impact on quality of life of antibody‐drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta‐analysis

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
This systematic review and meta‐analysis examined RCTs comparing antibody‐drug conjugates (T‐DM1, T‐DXd and SG) with standard therapies for metastatic breast cancer. It assessed adverse events, treatment discontinuation due to toxicity and quality of life using the EORTC QLQ‐C30 scale.
Marta Perachino   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy